Skip to main content

Pa. Woman Awarded $120M in Ethicon's Defective Mesh Case

Pa. Woman Awarded $120M in Ethicon's Defective Mesh Case

Pa. Woman Awarded $120M in Ethicon's Defective Mesh Case

Introduction

On Wednesday, April 24, a Philadelphia jury awarded $120 million to a woman who claimed she suffered incontinence and chronic pain due to Ethicon Inc.'s defectively designed transvaginal mesh.

The trial involved claims filed by a Pennsylvania woman who was implanted with J&J and Ethicon’s TVT-O pelvic implant to treat her urinary stress incontinence. She complained that the negligent design of the mesh caused it to erode into the soft tissue in her pelvis and injured her vagina, she had to undergo multiple surgeries to remove broken pieces of the mesh, but some fragments still remained in her body. She alleged that the complications prevented her from having sex for the last 10 years. The trial began in September 2018 and left the jury deadlocked on whether the mesh actually caused her injuries. The retrial, which began in March, was halted for a month when an expert witness suffered a heart attack. Wednesday's verdict includes $20 million in compensatory damages and $100 million in punitive damages.

There are more than 48,000 lawsuits filed against various transvaginal mesh manufacturers over devastating injuries caused due to their faulty designs. The FDA recently ordered a halt on the sale and distribution of all transvaginal mesh in the U.S.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!